SCHEMBL17366361

SCHEMBL17366361

Cc1cccc(N(c2ccc(/C=C/C=N/N(c3ccccc3)c3ccccc3)cc2)c2ccc(/C=C/C=N/N(c3ccccc3)c3ccccc3)cc2)c1C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.36
ALDH1A1 P00352 2/20 0.36
CYP1A2 P05177 2/20 0.33
CYP2C19 P33261 2/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
RELA Q04206 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
NPC1 O15118 1/20 0.32
LMNA P02545 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
THRB P10828 2/20 0.31
HPGD P15428 2/20 0.31
MAPT P10636 3/20 0.31
GAA P10253 2/20 0.31
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13291598 0.84 MAOB (0.44) HTTALDH1A1CYP2C19CYP3A4CYP2D6
SCHEMBL10938512 0.82 KMT2A (0.42) HTTALDH1A1CYP1A2CYP2C19CYP3A4
SCHEMBL17366373 0.81 ALDH1A1 (0.40) HTTALDH1A1CYP1A2CYP2C19CYP3A4
SCHEMBL17366377 0.81 HPGD (0.35) HTTALDH1A1CYP1A2CYP2C19CYP3A4
SCHEMBL17366360 0.80 MAOB (0.45) HTTALDH1A1CYP1A2CYP2C19CYP3A4
SCHEMBL21208372 0.80 KMT2A (0.40) HTTALDH1A1CYP1A2CYP2C19CYP3A4
SCHEMBL17366378 0.78 MAPT (0.40) HTTALDH1A1CYP1A2CYP2C19CYP3A4
SCHEMBL17367920 0.78 ALDH1A1 (0.54) HTTALDH1A1CYP1A2CYP2C19CYP3A4
SCHEMBL7890806 0.76 ALDH1A1 (0.38) HTTALDH1A1CYP1A2CYP2C19CYP3A4
SCHEMBL7891040 0.76 ALDH1A1 (0.43) ALDH1A1CYP3A4RELAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2960229-B1 HYDRAZONE DERIVATIVE OF TRIPHENYLAMINE AND ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER KYOCERA DOCUMENT SOLUTIONS INC (JP) 2017-02-15 EP disclosed
US-9454091-B2 Hydrazone derivative of triphenylamine and electrophotographic photosensitive member KYOCERA DOCUMENT SOLUTIONS INC. (JP) 2016-09-27 US disclosed
US-9454091-B2 Hydrazone derivative of triphenylamine and electrophotographic photosensitive member KYOCERA DOCUMENT SOLUTIONS INC. (JP) 2016-09-27 US disclosed
US-20150378269-A1 HYDRAZONE DERIVATIVE OF TRIPHENYLAMINE AND ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER KYOCERA DOCUMENT SOLUTIONS INC. (JP) 2015-12-31 US disclosed
US-20150378269-A1 HYDRAZONE DERIVATIVE OF TRIPHENYLAMINE AND ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER KYOCERA DOCUMENT SOLUTIONS INC. (JP) 2015-12-31 US disclosed
EP-2960229-A1 HYDRAZONE DERIVATIVE OF TRIPHENYLAMINE AND ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER Kyocera Document Solutions Inc. (JP) 2015-12-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150378269-A1 HYDRAZONE DERIVATIVE OF TRIPHENYLAMINE AND ELECTROPHOTOGRAPHIC PHOTOSENSITIVE MEMBER NAT1, GSTA1, PKN1 HTT 223/4885ALDH1A1 49/4885CYP1A2 250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.